CMET-17. RENAL CELL CARCINOMA BRAIN METASTASES TREATED WITH STEREOTACTIC RADIATION THERAPY AND NIVOLUMAB DOES NOT ALTER LESIONAL OR CLINICAL OUTCOMES

Metastases (BM) carries the risk of hemorrhaging lesions and can be effectively treated using stereotactic radiotherapy (SRT). Nivolumab is a recently approved immunotherapy for stage IV RCC. We evaluate whether patients with RCC BM treated with SRT overlapping with nivolumab have altered clinical a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Mohammadi, Homan, Tolpin, Aaron, Figura, Nicholas, Peacock, Jeffrey, Oliver, Daniel, Sim, Austin, Palm, Russel, Ahmed, Kamran, Liu, James, Tran, Nam, Etame, Arnold, Vogelbaum, Michael, Robinson, Timothy, Yu, Michael
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
CNS Metastasis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847278/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.218
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars